News

Suggestions that rheumatoid arthritis (RA) patients suffer more cardiovascular events when treated with Janus kinase (JAK) inhibitors compared with tumor necrosis factor (TNF) blockers or other ...
No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.
Only half of patients showed clinical improvement attributed to the medication, but only one new complication occurred.
Duskfade is a love letter to classic action-platformer games, and it's out next year.
Portuguese sneaker brand JAK launches in the UK exclusively at Selfridges. Known for ethically sourced, high-quality leather ...
Jakarta the capital of Indonesia an urban melting pot of 15 million people has hundreds of ethnic groups with different tribes and many Indonesian local languages However one thing can bring them ...
Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.
The off-label use of JAK inhibitors to treat JDM is common in pediatric rheumatology, with barriers to use including limited clinical trial data and insurance approval.
A prospective registry study found a greater risk for infections associated with JAK inhibitors in adolescents and adults with moderate to severe atopic dermatitis compared with biologics.